# Labcorp Drug Development – FDA Inspection, Jun 17, 2021

Source: https://www.keypedia.com/records/fda_inspections/labcorp-drug-development/0660c639-f996-40ed-a7c4-41507f3a7f5f
Source feed: FDA_Inspections

> FDA inspection 1147393 of Labcorp Drug Development, June 17, 2021. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1147393
- Company Name: Labcorp Drug Development
- Inspection Date: 2021-06-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1168630 - 2022-04-25](https://www.keypedia.com/records/fda_inspections/labcorp-drug-development/a50d857a-14b9-4f79-ab98-34070136da78)
- FDA Inspection 1123056 - 2020-03-05
- [FDA Inspection 1064469 - 2018-07-19](https://www.keypedia.com/records/fda_inspections/labcorp-drug-development/c78bb744-2d8a-40c2-8327-03479ad282f0)
- FDA Inspection 1022660 - 2017-07-26
- FDA Inspection 790402 - 2012-07-13

Company: https://www.keypedia.com/companies/labcorp-drug-development/590644d8-047e-4701-b6f2-fcb4b881a7a1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c